Submitted by drupal on Sat, 10/27/2012 - 5:02pm NCT00329082 Solanezumab United States Monday, May 1, 2006 – Saturday, May 31, 2008 25 Phase 2 Alzheimer's Disease Eli Lilly & Co. Comments No Available Comments Make a Comment To make a comment you must login or register.
Submitted by drupal on
Submitted by drupal on
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.